VNN3 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-VNN3 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityVNN3
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat
Isotypen/a
Formatpeptide affinity purified
Size0.1 mg
Concentration1 mg/mL
ApplicationsELISA (EIA), Western Blot (WB), Immunohistochemistry (IHC)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: Multiple isoforms of VNN3 are known to exist. VNN3 Antibody: The vanin family is a novel group of ectoenzymes that function in tissue repair and plays a role in oxidative-stress response. As both secreted and membrane proteins, the vanin family members have been implicated as therapeutic targets in inflammatory disease. VNN3 (vascular non-inflammatory molecule 3), also known as Vanin3, is a 501 amino acid GPI-anchored amidohydrolase that is widely expressed and is found at highest levels in blood and liver. Induced by Th17 / Th1 type cytokines, VNN3 converts pantetheine into pantothenic acid. Containing one CN hydrolase domain, VNN3 is encoded by a gene that maps to human chromosome 6q23.2.
ImmunogenImmunogen: VNN3 antibody was raised against a 19 amino acid synthetic peptide near the carboxy terminus of human VNN3. Buffer: VNN3 Antibody is supplied in PBS containing 0.02% sodium azide.
Other Names[VNN3; HSA238982; Vascular non-inflammatory molecule 3; Vanin-3; vanin 3], [VNN3; VNN3; HSA238982; Vanin-3]
Gene, Accession #[VNN3], Gene ID: 55350, NCBI: Q9NY84.2, UniProt: Q9NY84
Catalog #MBS153472
Price$375
Order / More InfoVNN3 Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.